<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-12T06:36:45Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.04190" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.04190</identifier>
    <datestamp>2022-10-26T11:17:46Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2022-10-26</dc:date>
  <dc:title>Raw data for a meta-analysis concerning the second-line treatment of small cell lung caner</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.04190</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>It remains unclear what the best second-line treatment is for patients with small-cell lung cancer (SCLC) sensitive to previous platinum-based chemotherapy. We performed a Bayesian network meta-analysis involving 1560 patients from 11 studies to identify the best second-line treatment for SCLC. We extracted raw data in this dataset.</dc:description>
  <dc:subject>small cell lung caner; second-line treatment;  netwotk meta-analysis</dc:subject>
  <dc:creator>Hekai Shi</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>